Year |
Citation |
Score |
2016 |
Han Y, Dai QC, Shen HL, Zhang XW. Diagnostic value of elevated serum miRNA-143 levels in sepsis. The Journal of International Medical Research. PMID 27225861 DOI: 10.1177/0300060516645003 |
0.403 |
|
2016 |
Chen X, Yan CC, Zhang X, You ZH, Deng L, Liu Y, Zhang Y, Dai Q. WBSMDA: Within and Between Score for MiRNA-Disease Association prediction. Scientific Reports. 6: 21106. PMID 26880032 DOI: 10.1038/srep21106 |
0.303 |
|
2015 |
Chen X, Clarence Yan C, Zhang X, Li Z, Deng L, Zhang Y, Dai Q. RBMMMDA: predicting multiple types of disease-microRNA associations. Scientific Reports. 5: 13877. PMID 26347258 DOI: 10.1038/srep13877 |
0.303 |
|
2015 |
Zeng YR, Han ZD, Wang C, Cai C, Huang YQ, Luo HW, Liu ZZ, Zhuo YJ, Dai QS, Zhao HB, Liang YX, Zhong WD. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer. Bmc Urology. 15: 90. PMID 26320076 DOI: 10.1186/s12894-015-0085-7 |
0.435 |
|
2015 |
Cai C, Chen QB, Han ZD, Zhang YQ, He HC, Chen JH, Chen Y, Yang SB, Wu YD, Zeng YR, Qin GQ, Liang YX, Dai QS, Jiang FN, Wu SL, et al. miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26080838 DOI: 10.1158/1078-0432.CCR-15-0217 |
0.438 |
|
2015 |
Cai C, Chen JY, Han ZD, He HC, Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, Zou J, Liang YX, Dai QS, Jiang FN, Zhong WD. Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer. International Journal of Clinical and Experimental Medicine. 8: 4186-94. PMID 26064329 |
0.457 |
|
2014 |
Zhang L, Liu J, Wang X, Li Z, Zhang X, Cao P, She X, Dai Q, Tang J, Liu Z. Upregulation of cytoskeleton protein and extracellular matrix protein induced by stromal-derived nitric oxide promotes lung cancer invasion and metastasis. Current Molecular Medicine. 14: 762-71. PMID 25056538 DOI: 10.2174/1566524014666140724103147 |
0.462 |
|
2014 |
Zhang X, Mao Y, Zheng R, Zheng Z, Huang Z, Huang D, Zhang J, Dai Q, Zhou X, Wen Y. The contribution of qualitative CEUS to the determination of malignancy in adnexal masses, indeterminate on conventional US - a multicenter study. Plos One. 9: e93843. PMID 24736589 DOI: 10.1371/journal.pone.0093843 |
0.302 |
|
2013 |
Liu H, Jia X, Wang F, Dai Q, Wang B, Bi J, Zhang C, Zhao L, Bai C, Hu Y, Zhang X. Synthesis of bis(N-arylcarboximidoylchloride)pyridine cobalt(II) complexes and their catalytic behavior for 1,3-butadiene polymerization. Dalton Transactions (Cambridge, England : 2003). 42: 13723-32. PMID 23907329 DOI: 10.1039/C3Dt51403J |
0.302 |
|
2013 |
Li T, Chen SL, Dai Q, Han XH, Li ZG, Wu DH, Zhang X, Gu JR, Yang NP, Sun LY, Zhang MJ, Li XF, Bao CD. Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial. Chinese Medical Journal. 126: 1867-71. PMID 23673101 |
0.301 |
|
2006 |
Dai Q, Gao W, Liu D, Kapes LM, Zhang X. Triazole-based monophosphine ligands for palladium-catalyzed cross-coupling reactions of aryl chlorides. The Journal of Organic Chemistry. 71: 3928-34. PMID 16674069 DOI: 10.1021/Jo060321E |
0.51 |
|
2006 |
Dai Q, Wang C, Zhang X. Chiral bisphospholane ligands (Me-ketalphos): synthesis of their Rh(I) complexes and applications in asymmetric hydrogenation Tetrahedron. 62: 868-871. DOI: 10.1016/J.Tet.2005.10.047 |
0.388 |
|
2005 |
Dai Q, Yang W, Zhang X. Efficient rhodium-catalyzed asymmetric hydrogenation for the synthesis of a new class of N-aryl beta-amino acid derivatives. Organic Letters. 7: 5343-5. PMID 16268574 DOI: 10.1021/ol0523897 |
0.303 |
|
2005 |
Liu D, Gao W, Dai Q, Zhang X. Triazole-based monophosphines for Suzuki-Miyaura coupling and amination reactions of aryl chlorides. Organic Letters. 7: 4907-10. PMID 16235919 DOI: 10.1021/Ol051844W |
0.466 |
|
2005 |
Liu D, Dai Q, Zhang X. A new class of readily available and conformationally rigid phosphino-oxazoline ligands for asymmetric catalysis Tetrahedron. 61: 6460-6471. DOI: 10.1016/J.Tet.2005.03.111 |
0.508 |
|
Show low-probability matches. |